506 related articles for article (PubMed ID: 7870229)
21. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE
Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and molecular basis of Glanzmann's thrombasthenia.
Perutelli P; Mori PG
Haematologica; 1992; 77(5):421-6. PubMed ID: 1483593
[TBL] [Abstract][Full Text] [Related]
23. [Familial occurrence of Glanzmann thrombasthenia].
Musiał J; Krzanowski M; Judkiewicz L; Cierniewski C
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):138-40. PubMed ID: 1437802
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
25. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect.
Gemmell CH; Sefton MV; Yeo EL
J Biol Chem; 1993 Jul; 268(20):14586-9. PubMed ID: 8325838
[TBL] [Abstract][Full Text] [Related]
26. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry.
Jennings LK; Ashmun RA; Wang WC; Dockter ME
Blood; 1986 Jul; 68(1):173-9. PubMed ID: 3719095
[TBL] [Abstract][Full Text] [Related]
27. Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia.
Burgess-Wilson ME; Cockbill SR; Johnston GI; Heptinstall S
Blood; 1987 Jan; 69(1):38-42. PubMed ID: 3098326
[TBL] [Abstract][Full Text] [Related]
28. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
[TBL] [Abstract][Full Text] [Related]
29. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors.
Sreedhara R; Itagaki I; Hakim RM
Am J Kidney Dis; 1996 Mar; 27(3):355-64. PubMed ID: 8604704
[TBL] [Abstract][Full Text] [Related]
30. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.
Burk CD; Newman PJ; Lyman S; Gill J; Coller BS; Poncz M
J Clin Invest; 1991 Jan; 87(1):270-6. PubMed ID: 1702098
[TBL] [Abstract][Full Text] [Related]
31. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.
Weiss HJ; Turitto VT; Baumgartner HR
Blood; 1986 Feb; 67(2):322-30. PubMed ID: 2935207
[TBL] [Abstract][Full Text] [Related]
32. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.
Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF
J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841
[TBL] [Abstract][Full Text] [Related]
33. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
[TBL] [Abstract][Full Text] [Related]
34. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
35. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
Clemetson KJ; Clemetson JM
Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological blockade of platelet GPIIb/IIIa and the inherited disorders of the platelet GPIIb/IIIa (Glanzmann's thrombasthenia): how safe is this antithrombotic approach for both acute and chronic treatment of thromboembolic disorders? Brief communication.
Mousa SA; Reilly TM
Cardiology; 1993; 83(1-2):36-7. PubMed ID: 8261484
[No Abstract] [Full Text] [Related]
37. Acquired Glanzmann's thrombasthenia: Diagnosis aided by platelet aggregation mixing study.
Compton F; Sarode R; Rutherford C; Curtis B; De Simone N
Haemophilia; 2020 Mar; 26(2):e41-e43. PubMed ID: 31985103
[No Abstract] [Full Text] [Related]
38. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.
Lawrence JB; Gralnick HR
J Lab Clin Med; 1987 Apr; 109(4):495-503. PubMed ID: 2434592
[TBL] [Abstract][Full Text] [Related]
40. [Platelet aggregations and glycoproteins].
Yamamoto N; Arai M; Tanoue K
Rinsho Byori; 1992 Mar; 40(3):272-81. PubMed ID: 1518178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
